if the FDA is going to pull Synthroid from the market

July 2001

Media reports have patients wondering if the FDA is going to pull Synthroid from the market.

This all started because levothyroxine has been on the market so long...many years before the FDA required New Drug Applications (NDA).

But all the potency problems that have plagued levothyroxine products have finally prompted the FDA to request an NDA for ALL levothyroxine products.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote